April 2, 2014 Critical Path Institute Receives Grant to Accelerate Development of Tuberculosis Treatments
October 10, 2013 CDISC SHARE and CFAST Integrally Linked: A Major Topic at the 2013 CDISC International Interchange
U.S. Food and Drug Administration and European Medicines Agency Reach Landmark Decisions on Critical Path Institute’s Clinical Trial Simulation Tool for Alzheimer’s Disease
CFAST Announces Parkinson’s Disease Drug Development Milestone: Release and Availability of a PD Therapeutic Area Data Standard
The National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments Consortium
